Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI boosts polyp detection in colonoscopy: over 5,000 tested

NCT ID NCT05322993

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether an AI system called GI Genius helps doctors spot polyps during colonoscopy. Over 5,000 adults participated. The goal was to see if AI improves detection rates and whether using AI has a lasting learning effect. Results could lead to better colon cancer screening.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
GI Genius artificial intelligence device
What this could lead to
If AI proves helpful, it could become a standard tool to improve colon cancer screening and reduce missed polyps.
What could go wrong
This trial is complete but only measures detection rates, not long-term health outcomes. AI may not reduce cancer risk or may cause unnecessary procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

5,034 people

The number who actually took part.

Started

Nov 2021

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients coming to outpatient clinics to perform colonoscopies Exclusion Criteria: * Total colectomy * Reservation against registration in Gastronet, the national quality register for colonoscopy in Norway

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colonic polyp are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Haraldsplass Deaconess Hospital

    Bergen, Vestland, 5009, Norway

  • Haukeland University Hospital

    Bergen, Vestland, 5021, Norway

  • Kanalspesialistene AS

    Bergen, Vestland, 5068, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.